Cargando…

Activation of UBEC2 by transcription factor MYBL2 affects DNA damage and promotes gastric cancer progression and cisplatin resistance

Ubiquitin-conjugating enzyme E2 C (UBE2C) plays a carcinogenic role in gastric cancer (GC); yet, its role in cisplatin (DDP) resistance in GC is enigmatic. This study sought to probe into the impact of UBE2C on DDP resistance in GC and its concrete molecular mechanism in GC progression. Bioinformati...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Jiegen, Zhu, Bin, Tian, Tao, Ren, Linfei, Tao, Yong, Zhu, Haitao, Li, Dengwei, Xu, Yonghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571520/
https://www.ncbi.nlm.nih.gov/pubmed/37840753
http://dx.doi.org/10.1515/med-2023-0757
_version_ 1785120019582025728
author Long, Jiegen
Zhu, Bin
Tian, Tao
Ren, Linfei
Tao, Yong
Zhu, Haitao
Li, Dengwei
Xu, Yonghong
author_facet Long, Jiegen
Zhu, Bin
Tian, Tao
Ren, Linfei
Tao, Yong
Zhu, Haitao
Li, Dengwei
Xu, Yonghong
author_sort Long, Jiegen
collection PubMed
description Ubiquitin-conjugating enzyme E2 C (UBE2C) plays a carcinogenic role in gastric cancer (GC); yet, its role in cisplatin (DDP) resistance in GC is enigmatic. This study sought to probe into the impact of UBE2C on DDP resistance in GC and its concrete molecular mechanism in GC progression. Bioinformatics analysis was used to analyze differentially expressed mRNAs and predict upstream regulatory molecules in GC. Real-time quantitative reverse transcriptase polymerase chain reaction and western blot were used to detect the expression of UBE2C and MYB proto-oncogene like 2 (MYBL2). Dual luciferase and chromatin immunoprecipitation (ChIP) assays were used to verify the binding relationship. Cell counting kit-8 was used to detect cell viability and calculate IC(50) values. Flow cytometry was used to detect the cell cycle. Comet assay was used to detect DNA damage. Western blot was used to detect the expression of DNA loss-related proteins (γ-H2AX, ATM/p-ATM). The knockdown of highly expressed UBE2C in GC cell lines could reduce cell viability, induce G2/M arrest, induce apoptosis, and promote DNA damage and DDP sensitivity. Bioinformatics analysis predicted that the substantially upregulated MYBL2 was an upstream transcription factor in UBE2C. The binding relationship between the UBE2C promoter region and MYBL2 was verified by dual luciferase and ChIP. Overexpression of UBE2C in the rescue experiment was found to reverse the inhibited GC progression and promoted DDP sensitivity brought by the knockdown of MYBL2. In conclusion, the MYBL2/UBE2C regulatory axis may be a potential way to overcome DDP resistance in GC.
format Online
Article
Text
id pubmed-10571520
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher De Gruyter
record_format MEDLINE/PubMed
spelling pubmed-105715202023-10-14 Activation of UBEC2 by transcription factor MYBL2 affects DNA damage and promotes gastric cancer progression and cisplatin resistance Long, Jiegen Zhu, Bin Tian, Tao Ren, Linfei Tao, Yong Zhu, Haitao Li, Dengwei Xu, Yonghong Open Med (Wars) Research Article Ubiquitin-conjugating enzyme E2 C (UBE2C) plays a carcinogenic role in gastric cancer (GC); yet, its role in cisplatin (DDP) resistance in GC is enigmatic. This study sought to probe into the impact of UBE2C on DDP resistance in GC and its concrete molecular mechanism in GC progression. Bioinformatics analysis was used to analyze differentially expressed mRNAs and predict upstream regulatory molecules in GC. Real-time quantitative reverse transcriptase polymerase chain reaction and western blot were used to detect the expression of UBE2C and MYB proto-oncogene like 2 (MYBL2). Dual luciferase and chromatin immunoprecipitation (ChIP) assays were used to verify the binding relationship. Cell counting kit-8 was used to detect cell viability and calculate IC(50) values. Flow cytometry was used to detect the cell cycle. Comet assay was used to detect DNA damage. Western blot was used to detect the expression of DNA loss-related proteins (γ-H2AX, ATM/p-ATM). The knockdown of highly expressed UBE2C in GC cell lines could reduce cell viability, induce G2/M arrest, induce apoptosis, and promote DNA damage and DDP sensitivity. Bioinformatics analysis predicted that the substantially upregulated MYBL2 was an upstream transcription factor in UBE2C. The binding relationship between the UBE2C promoter region and MYBL2 was verified by dual luciferase and ChIP. Overexpression of UBE2C in the rescue experiment was found to reverse the inhibited GC progression and promoted DDP sensitivity brought by the knockdown of MYBL2. In conclusion, the MYBL2/UBE2C regulatory axis may be a potential way to overcome DDP resistance in GC. De Gruyter 2023-10-11 /pmc/articles/PMC10571520/ /pubmed/37840753 http://dx.doi.org/10.1515/med-2023-0757 Text en © 2023 the author(s), published by De Gruyter https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License.
spellingShingle Research Article
Long, Jiegen
Zhu, Bin
Tian, Tao
Ren, Linfei
Tao, Yong
Zhu, Haitao
Li, Dengwei
Xu, Yonghong
Activation of UBEC2 by transcription factor MYBL2 affects DNA damage and promotes gastric cancer progression and cisplatin resistance
title Activation of UBEC2 by transcription factor MYBL2 affects DNA damage and promotes gastric cancer progression and cisplatin resistance
title_full Activation of UBEC2 by transcription factor MYBL2 affects DNA damage and promotes gastric cancer progression and cisplatin resistance
title_fullStr Activation of UBEC2 by transcription factor MYBL2 affects DNA damage and promotes gastric cancer progression and cisplatin resistance
title_full_unstemmed Activation of UBEC2 by transcription factor MYBL2 affects DNA damage and promotes gastric cancer progression and cisplatin resistance
title_short Activation of UBEC2 by transcription factor MYBL2 affects DNA damage and promotes gastric cancer progression and cisplatin resistance
title_sort activation of ubec2 by transcription factor mybl2 affects dna damage and promotes gastric cancer progression and cisplatin resistance
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571520/
https://www.ncbi.nlm.nih.gov/pubmed/37840753
http://dx.doi.org/10.1515/med-2023-0757
work_keys_str_mv AT longjiegen activationofubec2bytranscriptionfactormybl2affectsdnadamageandpromotesgastriccancerprogressionandcisplatinresistance
AT zhubin activationofubec2bytranscriptionfactormybl2affectsdnadamageandpromotesgastriccancerprogressionandcisplatinresistance
AT tiantao activationofubec2bytranscriptionfactormybl2affectsdnadamageandpromotesgastriccancerprogressionandcisplatinresistance
AT renlinfei activationofubec2bytranscriptionfactormybl2affectsdnadamageandpromotesgastriccancerprogressionandcisplatinresistance
AT taoyong activationofubec2bytranscriptionfactormybl2affectsdnadamageandpromotesgastriccancerprogressionandcisplatinresistance
AT zhuhaitao activationofubec2bytranscriptionfactormybl2affectsdnadamageandpromotesgastriccancerprogressionandcisplatinresistance
AT lidengwei activationofubec2bytranscriptionfactormybl2affectsdnadamageandpromotesgastriccancerprogressionandcisplatinresistance
AT xuyonghong activationofubec2bytranscriptionfactormybl2affectsdnadamageandpromotesgastriccancerprogressionandcisplatinresistance